Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative oliceridine versus sufentanil for postoperative ileus after laparoscopic gastric surgery
ChiCTR2400089422Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Sep 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of oliceridine and sufentanil in postoperative ileus (POI) (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: Time from end of surgery to first bowel movement. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
oliceridinesufentanil
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on ChiCTR2400089422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089422.